ABSTRACT

SARS (Severe Acute Respiratory Syndrome) is a type of acute respiratory syndrome. The present COVID-19 pandemic is caused by Coronavirus 2. (SARS-CoV-2). This virus is rapidly spreading across the globe, particularly in India. Supportive therapy, eating, and preventing further development are the pillars of disease therapy inside the event of non - compliance drug treatments. Traditional medicines have been found to be both safe and effective, as well as popular. Traditional Ayurvedic treatments that have now been evaluated in clinical trials versus COVID-19 are also mentioned, as well as the progress of also before the and clinical testing of potent herbal remedies against COVID-19 and SARS-CoV-2. The findings of clinical trials on Siddha pharmaceuticals will help policymakers in the AYUSH medical systems navigate public health policies, give information to the worldwide scientific community, and perhaps serve as a platform for collaborative research at the national and global levels. To address the present problem, it is advised that potential Siddha formulations and Indian medicinal herbs be explored as soon as possible. Keywords: Siddha, Traditional formulations, COVID-19, SARS, Respiratory illness
Publication date: 01/12/2022

https://ijbpas.com/pdf/2022/December/MS_IJBPAS_2022_6683.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2022/11.12.6683